Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
hepatitis b vaccine (recombinant) (recombivax) (1 trial)
glycerol phenylbutyrate (ravicti) (1 trial)
levocarnitine (carnitor) (1 trial)
vitamin q (1 trial)
enoxacin (penetrex) (1 trial)
carfilzomib (kyprolis) (1 trial)
cyclosporine (sandimmune) (1 trial)
dexamethasone (1 trial)
human fecal microbiota (Reybota) (6 trials)
wst 11-mediated vtp therapy (1 trial)
agar (1 trial)
autologous fecal microbiota (1 trial)
cetuximab (erbitux) (1 trial)
ciprofloxacin (cipro) (2 trials)
fiber (1 trial)
metformin (glucophage) (1 trial)
methylphenidate (ritalin) (1 trial)
metronidazole (flagyl) (2 trials)
pegph20 (1 trial)
vaginal microbiome (1 trial)
Deglutition Disorders (Phase 1)
Dermatitis (Phase 1)
Dermatitis, Atopic (Phase 1)
Eczema (Phase 1)
Hepatitis B (Phase 4)
Myelodysplastic Syndromes (Phase 3)
Preleukemia (Phase 3)
Syndrome (Phase 3)
Trials (18 total)
Trial APIs (20 total)